Newer devices and improved formulations of inhaled insulin
Author:
Publisher
Informa Healthcare
Subject
Pharmaceutical Science
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425247.2015.990436
Reference70 articles.
1. Oral Antidiabetic Agents
2. Use of Antidiabetic Drugs in the U.S., 2003–2012
3. Insulin Therapy for Type 2 Diabetes Mellitus
4. Advances in insulin delivery systems and devices: Beyond the vial and syringe
5. Insulin Delivery Device Technology 2012: Where are We after 90 Years?
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insulin Analogs and the Mode of Insulin Delivery: Recent Advances and Challenges;Current Pharmaceutical Biotechnology;2024-04-02
2. Review of point-of-care platforms for diabetes: (2) medications and devices;Sensors and Actuators Reports;2023-06
3. Not all nebulizers are created equal: Considerations in choosing a nebulizer for aerosol delivery during mechanical ventilation;Expert Review of Respiratory Medicine;2023-02-01
4. Formulation and Pharmacokinetic Challenges Associated with Targeted Pulmonary Drug Delivery;Drug Delivery Approaches;2021-07-27
5. Recent Advances in Inhaled Formulations and Pulmonary Insulin Delivery Systems;Current Pharmaceutical Biotechnology;2020-03-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3